AWS re:Invent 2014 | (HLS305) Transforming Cancer Treatment: Data & Promise of Precision Medicine

Опубликовано 9 января 2015, 23:42

In the past ten years, the cost of sequencing a human genome has fallen from $3 billion dollars to $1,000, unlocking the ability for clinicians to use genomics in routine care. As the volume of genomic data used in the clinic begins to grow, healthcare providers are facing a number of new IT challenges, such as how to integrate this data with clinical data stored in electronic medical records, and how to make both available in real time to inform clinical decisions. In this session, find out how UCSF Medical Center and Syapse met these challenges head-on and solved them using AWS, all while remaining compliant with privacy and security requirements. Learn how Syapse's precision medicine platform uses Amazon VPC, Dedicated Instances, Amazon EC2, and Amazon EBS to build a high performance, scalable, and HIPAA-compliant data platform that enables UCSF to deliver on the promise of precision medicine by dramatically reducing time and increasing the accuracy and utility of genomic profiling in cancer treatment.